Cargando…
Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization
Betulinic acid (BA), a pentacyclic triterpene, represents a new therapeutic substance that has potential benefits for treating glioblastoma. Recently, new strategies for producing BA derivatives with improved properties have evolved. However, few studies have examined the combination of BA or BA der...
Autores principales: | Bache, Matthias, Bernhardt, Stephan, Passin, Sarina, Wichmann, Henri, Hein, Anja, Zschornak, Martin, Kappler, Matthias, Taubert, Helge, Paschke, Reinhard, Vordermark, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264138/ https://www.ncbi.nlm.nih.gov/pubmed/25361208 http://dx.doi.org/10.3390/ijms151119777 |
Ejemplares similares
-
Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions
por: Bache, Matthias, et al.
Publicado: (2011) -
Effects of Topically Applied Betulinic Acid and NVX-207 on Melanocytic Tumors in 18 Horses
por: Weber, Lisa A., et al.
Publicado: (2021) -
Effects of osteopontin inhibition on radiosensitivity
of MDA-MB-231 breast cancer cells
por: Hahnel, Antje, et al.
Publicado: (2010) -
Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells
por: Bache, Matthias, et al.
Publicado: (2015) -
SESN2 Knockdown Increases Betulinic Acid-Induced Radiosensitivity of Hypoxic Breast Cancer Cells
por: Güttler, Antje, et al.
Publicado: (2022)